BioSpace News Archive

Business

AscellaHealth Forges Strategic Alliance with Optime Care: Expands Portfolio of Innovative Services for Specialty Pharmacy Industry and Enhances Focus on Rare Diseases and Cell/Gene Therapies

AscellaHealth, a global specialty pharmacy and healthcare solutions company, today announces its strategic alliance with Optime Care to further enhance its ability to become a leader in Specialty Pharmacy (SP) services and establish a strong trajectory for growth.

December 16, 2021
·
4 min read
Drug Development

Kura Oncology Doses First Patient in Phase 1/2 Clinical Trial of Tipifarnib in Combination with Alpelisib in Head and Neck Squamous Cell Carcinoma

Kura Oncology, Inc. (Nasdaq: KURA), today announced dose administration for the first patient in KURRENT, the Company’s Phase 1/2 clinical trial of tipifarnib in combination with alpelisib in patients with HRAS- and/or PIK3CA-dependent head and neck squamous cell carcinoma (HNSCC).

December 16, 2021
·
6 min read
Business

Bluejay Diagnostics, Inc. Reports Third Quarter 2021 Financial Results

Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”) today announced financial results for the third quarter ended September 30, 2021 and provided a corporate update on the Company’s first product candidate, the IL-6 test for sepsis triage.

December 16, 2021
·
10 min read
Pharm Country

Legend Biotech Corporation Announces Pricing of Public Offering - Dec 16, 2021

Legend Biotech Corporation announced that it has priced an underwritten public offering of 7,500,000 American depositary shares, each representing two ordinary shares, at a public offering price of $40.00 per ADS, for total gross proceeds of approximately $300.0 million.

December 16, 2021
·
5 min read
Job Trends

AstraZeneca supports the growth of the C3i Lymphoma Registry, a project led by Dr. Isabelle Fleury at Hôpital Maisonneuve-Rosemont

The C3i Center (C3i) is proud to announce the participation of AstraZeneca Canada (AstraZeneca) in supporting the development of the Lymphoma Registry.

December 16, 2021
·
3 min read
Biotech Beach

Denovo Biopharma LLC Announces Breakthrough Discovery of a Novel Genetic Biomarker for DB107 for a Gene Therapy-Based Medicine

Denovo Biopharma LLC (“Denovo”), a pioneer in applying precision medicine to the development of innovative therapies, today announced it discovered a novel genetic biomarker, Denovo Genomic Marker 7 (DGM7 TM), using its proprietary biomarker discovery platform.

December 16, 2021
·
3 min read
Biotech Beach

City of Hope presents leading-edge research on blood cancer therapies and its vaccine to reduce stem cell transplant complications at American Society of Hematology (ASH) Annual Meeting

City of Hope doctors presented data on an investigational bispecific antibody for multiple myeloma and the CMVPepVax, a City of Hope-developed vaccine against the cytomegalovirus, at this year’s ASH Annual Meeting.

December 16, 2021
·
10 min read
Biotech Beach

Vero Diagnostics Lab Launches Ultra-Rapid Covid-19 PCR Testing in Los Angeles

Vero Diagnostics, a CLIA high complexity & CAP certified, state-of-the-art laboratory, announced the launch of the Baebies® FINDER® 1.5 ultra-rapid SARS-CoV-2 RT-PCR testing platform to Vero Diagnostics customers in Los Angeles.

December 16, 2021
·
2 min read
Job Trends

EVUSHELD long-acting antibody combination retains neutralizing activity against Omicron variant in independent FDA study

AstraZeneca’s EVUSHELD (tixagevimab co-packaged with cilgavimab), a long-acting antibody combination for the prevention of COVID-19, retained neutralizing activity against the Omicron SARS-CoV-2 variant (B.1.1.529), according to new preclinical data.

December 16, 2021
·
13 min read
Biotech Bay

Curebase Technology Key to metaMe Health’s FDA Clearance of Regulora

Curebase, a company committed to democratizing access to clinical studies, is pleased to have served as the technology partner for metaMe Health’s Regulora®, the first FDA-authorized treatment of any kind specifically for abdominal pain associated with irritable bowel syndrome (IBS) in adults.

December 16, 2021
·
2 min read